Streetbeat News

MEDS

TRxADE HEALTH, Inc.

https://www.trxadehealth.com

Industry

Medical - Pharmaceuticals

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Open

7.25

Mkt cap

13M

Volume

19K

High

7.70

P/E Ratio

-0.31

52-wk high

44.56

Low

7.06

Div yield

1.25

52-wk low

3.69

TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares have surged over 40% in a single session and over 160% in the last 30 days, despite no company-specific news. The stock has seen heavy trading volume, with over 10 million shares traded in the session, significantly higher than the 100-day average of 654 thousand shares. Last week, the company announced that Superlatus, a company it recently merged with, agreed to acquire The Urgent Company and its portfolio of brands.

Portfolio Pulse from Erica Kollmann

September 01, 2023 | 3:35 pm

US stocks traded higher following the release of jobs data, with the Dow, NASDAQ, and S&P 500 all seeing gains. The US economy added 187,000 jobs in August, exceeding market expectations. Energy shares jumped by 1.7%, while consumer staples shares rose by 0.3%. Taoping Inc., Edible Garden AG Incorporated, and TRxADE HEALTH, Inc. saw significant increases in their share prices. However, Aditxt, Inc., Akso Health Group, and iCoreConnect Inc. saw their share prices drop.

Portfolio Pulse from Lisa Levin

September 01, 2023 | 1:52 pm

During Friday's pre-market session, several health care stocks experienced significant movement. Trxade Health, Novo Integrated Sciences, Axcella Health, 23andMe Holding, Virpax Pharmaceuticals, and Celularity saw gains, while Aditxt, Biodexa Pharmaceuticals, Acer Therapeutics, Aravive, Allarity Therapeutics, and Xtant Medical Hldgs experienced losses.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 1:06 pm

Trxade Health Inc (NASDAQ:MEDS) shares are trading higher after the company announced that Superlatus, the food technology and distribution company it recently merged with, agreed to acquire The Urgent Company and its portfolio of brands. The brands are sold in over 6,000 stores including Whole Foods, Kroger, Costco and Thrive Market. The deal is expected to strengthen Superlatus' position in the sustainable food products space.

Portfolio Pulse from Adam Eckert

August 22, 2023 | 4:16 pm

TRxADE HEALTH's shares are trading higher following the acquisition of The Urgent Company by Superlatus, which recently merged with TRxADE HEALTH.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 4:13 pm

TRxADE HEALTH has announced that its recently merged entity, Superlatus, will acquire The Urgent Company. The terms of the deal have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 12:08 pm

Trxade Health (NASDAQ:MEDS) is set to release its latest quarterly earnings report on August 18, 2023. Analysts estimate an earnings per share (EPS) of $-0.75. The company's past performance shows a trend of share price drops following earnings reports. The stock is currently trading at $7.38, down 61.26% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 2:01 pm

Several healthcare stocks experienced significant movement in Monday's pre-market session. Zynerba Pharmaceuticals, Taysha Gene Therapies, Virios Therapeutics, Nemaura Medical, Trxade Health, and Mainz Biomed saw gains, while BioXcel Therapeutics, Science 37 Hldgs, PHAXIAM Therapeutics, Fortrea Holdings, NovaBay Pharmaceuticals, and Valneva experienced losses. Q2 earnings reports were recently released for several of these companies.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:06 pm

Trxade Health (NASDAQ:MEDS) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.75. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $9.0, down 59.52% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 4:02 pm

In Friday's after-market session, several health care stocks experienced significant movement. Gainers included Akso Health Group (AHG), T2 Biosystems (TTOO), MSP Recovery (LIFW), Context Therapeutics (CNTX), Soligenix (SNGX), and Sonendo (SONX). Losers included Tivic Health Systems (TIVC), Aceragen (ACGN), Biodexa Pharmaceuticals (BDRX), Trxade Health (MEDS), iBio (IBIO), and TC BioPharm (TCBP).

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 9:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.